EUVIMEDEUVIMED entdecken
Open Access

Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM

Jorge L Jimenez-Macias iD, Philippa Vaughn-Beaucaire iD, Ayush Bharati iD, Zheyun Xu iD, Megan Forrest, Jason Hong, Michael Sun, Andrea Schmidt iD, Jasmine Clark, William Hawkins, Noe Mercado iD, Jacqueline Real und 14 weitere

Science Advances · 28.02.2025 · 11 (9)

DOI: 10.1126/sciadv.adr1481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 28.02.2025. Verfasst von Jorge L Jimenez-Macias und 25 weiteren Autor:innen. Beteiligte Einrichtung: Legorreta Cancer Center, Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02903, USA. Hauptthemen laut MEDLINE: Glioblastoma, Blood-Brain Barrier, Brain Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient drug delivery to glioblastoma (GBM) is a major obstacle as the blood-brain barrier (BBB) and the blood-tumor barrier (BTB) prevent passage of the majority of chemotherapies into the brain. Here, we identified a transcriptional 12-gene signature associated with the BTB in GBM. We identified CDH5 as a core molecule in this set and confirmed its expression in GBM vasculature using transcriptomics and immunostaining of patient specimens. The indirubin-derivative, 6-bromoindirubin acetoxime (BIA), down-regulates CDH5 and other BTB signature genes, causing endothelial barrier disruption in vitro and in murine GBM xenograft models. Treatment with BIA increased intratumoral cisplatin accumulation and potentiated DNA damage by targeting DNA repair pathways. Last, using an injectable BIA nanoparticle formulation, PPRX-1701, we significantly improved cisplatin efficacy in murine GBM. Our work reveals potential targets of the BTB and the bifunctional properties of BIA as a BTB modulator and a potentiator of chemotherapy, supporting its further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBlood-Brain BarrierBrain NeoplasmsDrug Delivery SystemsAntineoplastic AgentsAnimalsHumansMiceCisplatinXenograft Model Antitumor AssaysCell Line, TumorGene Expression Regulation, NeoplasticCadherinsNanoparticles

Substanzen

CisplatinAntineoplastic AgentsCadherins

Autor:innen und Institutionen

  • Legorreta Cancer Center, Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02903, USA.
  • Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA.
  • Harvard Stem Cell Institute, Harvard University, Boston, MA 02115, USA.
  • Cytodigm Inc, Natick, MA 01760, USA.

ORCID-Profile: Jorge L Jimenez-Macias, Philippa Vaughn-Beaucaire, Ayush Bharati, Zheyun Xu, Andrea Schmidt, Noe Mercado, Kelsey Huntington, Michal O Nowicki, Choi-Fong Cho, Bin Wu, Theresa Logan, Katherine E Manz, Kurt D Pennell, Bogdan I Fedeles, Paul Bertone, Alexander S Brodsky, Sean E Lawler

Förderung

  • NCI NIH HHS
  • NIEHS NIH HHS

Zitieren

APA

Jimenez-Macias, J. L., Vaughn-Beaucaire, P., Bharati, A., Xu, Z., Forrest, M., Hong, J., Sun, M., Schmidt, A., Clark, J., Hawkins, W., Mercado, N., Real, J., Huntington, K., Zdioruk, M., Nowicki, M. O., Cho, C. F., Wu, B., Li, W., Logan, T., …, & Lawler, S. E. (2025). Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM. Science Advances, 11(9). https://doi.org/10.1126/sciadv.adr1481

Vancouver

Jimenez-Macias JL, Vaughn-Beaucaire P, Bharati A, Xu Z, Forrest M, Hong J, et al. Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM. Science Advances. 2025;11(9). doi:10.1126/sciadv.adr1481

BibTeX
@article{JimenezMacias2025,
  author = {Jimenez-Macias, Jorge L and Vaughn-Beaucaire, Philippa and Bharati, Ayush and Xu, Zheyun and Forrest, Megan and Hong, Jason and Sun, Michael and Schmidt, Andrea and Clark, Jasmine and Hawkins, William and Mercado, Noe and Real, Jacqueline and Huntington, Kelsey and Zdioruk, Mykola and Nowicki, Michal O and Cho, Choi-Fong and Wu, Bin and Li, Weiyi and Logan, Theresa and Manz, Katherine E and Pennell, Kurt D and Fedeles, Bogdan I and Bertone, Paul and Punsoni, Michael and Brodsky, Alexander S and Lawler, Sean E},
  title = {Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {9},
  doi = {10.1126/sciadv.adr1481}
}
Kostenlos starten →